The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(3-(4-methoxyphenylthio)-6-(4-methyl-4H-1,2,4-triazol-3-ylthio)picolinamido)thiazol-5-ylthio)acetic acid ID: ALA4062363
PubChem CID: 76902401
Max Phase: Preclinical
Molecular Formula: C21H18N6O4S4
Molecular Weight: 546.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(Sc2ccc(Sc3nncn3C)nc2C(=O)Nc2ncc(SCC(=O)O)s2)cc1
Standard InChI: InChI=1S/C21H18N6O4S4/c1-27-11-23-26-21(27)34-15-8-7-14(33-13-5-3-12(31-2)4-6-13)18(24-15)19(30)25-20-22-9-17(35-20)32-10-16(28)29/h3-9,11H,10H2,1-2H3,(H,28,29)(H,22,25,30)
Standard InChI Key: MJHNYEFAOUYNSZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
4.1506 -11.4530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1494 -12.2726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8575 -12.6815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5671 -12.2721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5643 -11.4494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8557 -11.0442 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4428 -11.0446 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.7352 -11.4534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9872 -11.1209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4406 -11.7284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8494 -12.4360 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6486 -12.2658 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2755 -12.6796 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.2768 -13.4968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5684 -13.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5693 -14.7213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2782 -15.1296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9876 -14.7155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9832 -13.9005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2806 -15.9468 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2705 -11.0382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9797 -11.4441 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2674 -10.2210 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6859 -11.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4330 -11.3612 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.9775 -10.7518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5662 -10.0456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7676 -10.2187 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.8170 -10.3217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8957 -9.2978 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.7081 -9.2093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0376 -8.4614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8500 -8.3729 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5547 -7.8022 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.5741 -16.3575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 2 0
4 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
5 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 24 1 0
9 29 1 0
27 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
32 34 2 0
20 35 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 546.68Molecular Weight (Monoisotopic): 546.0272AlogP: 4.41#Rotatable Bonds: 10Polar Surface Area: 132.12Molecular Species: ACIDHBA: 12HBD: 2#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 3.05CX Basic pKa: 1.51CX LogP: 4.02CX LogD: 0.71Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.27Np Likeness Score: -1.83
References 1. Xu J, Lin S, Myers RW, Trujillo ME, Pachanski MJ, Malkani S, Chen HS, Chen Z, Campbell B, Eiermann GJ, Elowe N, Farrer BT, Feng W, Fu Q, Kats-Kagan R, Kavana M, McMasters DR, Mitra K, Tong X, Xu L, Zhang F, Zhang R, Addona GH, Berger JP, Zhang B, Parmee ER.. (2017) Discovery of orally active hepatoselective glucokinase activators for treatment of Type II Diabetes Mellitus., 27 (9): [PMID:28284809 ] [10.1016/j.bmcl.2016.10.088 ]